Innovation is accelerating progress in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions bring together advanced formulation design, real-time dose flexibility, and world-class CMC expertise to si...
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
ICON Acquires MeDiNova Research Site in Europe & Africa
This recent Applied Clinical Trials article discusses ICON's acquisition of majority shareholding in MeDiNova Research, a site network with research sites in Europe and Africa, granting our company the right to acquire the remaining shares in the company by the third quarter of 2020. MeDiNova Research currently has a network of 33 active clinical research sites in the UK, Spain, South Africa, Poland and Romania.
-
Patient Engagement Web Platform from ICON Bolsters Clinical Connectivity
An Outsourcing Pharma article featuring commentary from experts EB McLindon & Gretchen Goller, on ICON’s new web-based patient engagement platform to provide patients with study-specific information and connectivity.
-
The rise of patient-centricity
In the April 2019 issue of Pharmaceutical Market Europe (PME), p.32-34, Matt McCarty discusses the importance of understanding what patients value and ways to gather patient insights.
-
Patients is a Virtue
As patients are increasingly using digital and social media as part of their consumer behaviour, it becomes important for healthcare to also be digitally enabled. In order to truly understand the value of direct patient engagement and advocacy, pharma companies need to take the time to understand how to grow successful, mutually beneficial relationships.
